Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 200

1.

A stromal cell niche sustains ILC2-mediated type-2 conditioning in adipose tissue.

Rana BMJ, Jou E, Barlow JL, Rodriguez-Rodriguez N, Walker JA, Knox C, Jolin HE, Hardman CS, Sivasubramaniam M, Szeto A, Cohen ES, Scott IC, Sleeman MA, Chidomere CI, Cruz Migoni S, Caamano J, Jorgensen HF, Carobbio S, Vidal-Puig A, McKenzie ANJ.

J Exp Med. 2019 Jun 27. pii: jem.20190689. doi: 10.1084/jem.20190689. [Epub ahead of print]

PMID:
31248899
2.

Polychromic Reporter Mice Reveal Unappreciated Innate Lymphoid Cell Progenitor Heterogeneity and Elusive ILC3 Progenitors in Bone Marrow.

Walker JA, Clark PA, Crisp A, Barlow JL, Szeto A, Ferreira ACF, Rana BMJ, Jolin HE, Rodriguez-Rodriguez N, Sivasubramaniam M, Pannell R, Cruickshank J, Daly M, Haim-Vilmovsky L, Teichmann SA, McKenzie ANJ.

Immunity. 2019 Jul 16;51(1):104-118.e7. doi: 10.1016/j.immuni.2019.05.002. Epub 2019 May 22.

3.

Group 2 Innate Lymphoid Cells Are Redundant in Experimental Renal Ischemia-Reperfusion Injury.

Cameron GJM, Cautivo KM, Loering S, Jiang SH, Deshpande AV, Foster PS, McKenzie ANJ, Molofsky AB, Hansbro PM, Starkey MR.

Front Immunol. 2019 Apr 16;10:826. doi: 10.3389/fimmu.2019.00826. eCollection 2019.

4.

BET Bromodomain Inhibitor iBET151 Impedes Human ILC2 Activation and Prevents Experimental Allergic Lung Inflammation.

Kerscher B, Barlow JL, Rana BM, Jolin HE, Gogoi M, Bartholomew MA, Jhamb D, Pandey A, Tough DF, van Oosterhout AJM, McKenzie ANJ.

Front Immunol. 2019 Apr 9;10:678. doi: 10.3389/fimmu.2019.00678. eCollection 2019.

5.

Spontaneous atopic dermatitis in mice with a defective skin barrier is independent of ILC2 and mediated by IL-1β.

Schwartz C, Moran T, Saunders SP, Kaszlikowska A, Floudas A, Bom J, Nunez G, Iwakura Y, O'Neill L, Irvine AD, McKenzie ANJ, Ogg G, Walsh PT, Demengeot J, Fallon PG.

Allergy. 2019 Apr 2. doi: 10.1111/all.13801. [Epub ahead of print]

PMID:
30937919
6.

Innate Lymphoid Cells of the Lung.

Barlow JL, McKenzie ANJ.

Annu Rev Physiol. 2019 Feb 10;81:429-452. doi: 10.1146/annurev-physiol-020518-114630.

PMID:
30742786
7.

Pulmonary group 2 innate lymphoid cells: surprises and challenges.

Starkey MR, McKenzie AN, Belz GT, Hansbro PM.

Mucosal Immunol. 2019 Mar;12(2):299-311. doi: 10.1038/s41385-018-0130-4. Epub 2019 Jan 21. Review.

PMID:
30664706
8.

MicroRNA-155 Protects Group 2 Innate Lymphoid Cells From Apoptosis to Promote Type-2 Immunity.

Knolle MD, Chin SB, Rana BMJ, Englezakis A, Nakagawa R, Fallon PG, Git A, McKenzie ANJ.

Front Immunol. 2018 Oct 9;9:2232. doi: 10.3389/fimmu.2018.02232. eCollection 2018.

9.

Genome-wide analyses reveal the IRE1a-XBP1 pathway promotes T helper cell differentiation by resolving secretory stress and accelerating proliferation.

Pramanik J, Chen X, Kar G, Henriksson J, Gomes T, Park JE, Natarajan K, Meyer KB, Miao Z, McKenzie ANJ, Mahata B, Teichmann SA.

Genome Med. 2018 Oct 24;10(1):76. doi: 10.1186/s13073-018-0589-3.

10.

Roles for T/B lymphocytes and ILC2s in experimental chronic obstructive pulmonary disease.

Donovan C, Starkey MR, Kim RY, Rana BMJ, Barlow JL, Jones B, Haw TJ, Mono Nair P, Budden K, Cameron GJM, Horvat JC, Wark PA, Foster PS, McKenzie ANJ, Hansbro PM.

J Leukoc Biol. 2019 Jan;105(1):143-150. doi: 10.1002/JLB.3AB0518-178R. Epub 2018 Sep 27.

11.

Concerted IL-25R and IL-4Rα signaling drive innate type 2 effector immunity for optimal helminth expulsion.

Smith KA, Löser S, Varyani F, Harcus Y, McSorley HJ, McKenzie AN, Maizels RM.

Elife. 2018 Sep 21;7. pii: e38269. doi: 10.7554/eLife.38269.

12.

Innate Lymphoid Cells: 10 Years On.

Vivier E, Artis D, Colonna M, Diefenbach A, Di Santo JP, Eberl G, Koyasu S, Locksley RM, McKenzie ANJ, Mebius RE, Powrie F, Spits H.

Cell. 2018 Aug 23;174(5):1054-1066. doi: 10.1016/j.cell.2018.07.017. Review.

PMID:
30142344
13.

Tissue-Restricted Adaptive Type 2 Immunity Is Orchestrated by Expression of the Costimulatory Molecule OX40L on Group 2 Innate Lymphoid Cells.

Halim TYF, Rana BMJ, Walker JA, Kerscher B, Knolle MD, Jolin HE, Serrao EM, Haim-Vilmovsky L, Teichmann SA, Rodewald HR, Botto M, Vyse TJ, Fallon PG, Li Z, Withers DR, McKenzie ANJ.

Immunity. 2018 Jun 19;48(6):1195-1207.e6. doi: 10.1016/j.immuni.2018.05.003. Epub 2018 Jun 12.

14.

Lack of Type 2 Innate Lymphoid Cells Promotes a Type I-Driven Enhanced Immune Response in Contact Hypersensitivity.

Rafei-Shamsabadi DA, van de Poel S, Dorn B, Kunz S, Martin SF, Klose CSN, Arnold SJ, Tanriver Y, Ebert K, Diefenbach A, Halim TYF, McKenzie ANJ, Jakob T.

J Invest Dermatol. 2018 Sep;138(9):1962-1972. doi: 10.1016/j.jid.2018.03.001. Epub 2018 Mar 9.

15.

CD1a presentation of endogenous antigens by group 2 innate lymphoid cells.

Hardman CS, Chen YL, Salimi M, Jarrett R, Johnson D, Järvinen VJ, Owens RJ, Repapi E, Cousins DJ, Barlow JL, McKenzie ANJ, Ogg G.

Sci Immunol. 2017 Dec 22;2(18). pii: eaan5918. doi: 10.1126/sciimmunol.aan5918.

16.

TH2 cell development and function.

Walker JA, McKenzie ANJ.

Nat Rev Immunol. 2018 Feb;18(2):121-133. doi: 10.1038/nri.2017.118. Epub 2017 Oct 30. Review.

PMID:
29082915
17.

Epidermal Growth Factor Receptor Expression Licenses Type-2 Helper T Cells to Function in a T Cell Receptor-Independent Fashion.

Minutti CM, Drube S, Blair N, Schwartz C, McCrae JC, McKenzie AN, Kamradt T, Mokry M, Coffer PJ, Sibilia M, Sijts AJ, Fallon PG, Maizels RM, Zaiss DM.

Immunity. 2017 Oct 17;47(4):710-722.e6. doi: 10.1016/j.immuni.2017.09.013.

18.

Tumour-derived PGD2 and NKp30-B7H6 engagement drives an immunosuppressive ILC2-MDSC axis.

Trabanelli S, Chevalier MF, Martinez-Usatorre A, Gomez-Cadena A, Salomé B, Lecciso M, Salvestrini V, Verdeil G, Racle J, Papayannidis C, Morita H, Pizzitola I, Grandclément C, Bohner P, Bruni E, Girotra M, Pallavi R, Falvo P, Leibundgut EO, Baerlocher GM, Carlo-Stella C, Taurino D, Santoro A, Spinelli O, Rambaldi A, Giarin E, Basso G, Tresoldi C, Ciceri F, Gfeller D, Akdis CA, Mazzarella L, Minucci S, Pelicci PG, Marcenaro E, McKenzie ANJ, Vanhecke D, Coukos G, Mavilio D, Curti A, Derré L, Jandus C.

Nat Commun. 2017 Sep 19;8(1):593. doi: 10.1038/s41467-017-00678-2.

19.

ILC2s regulate adaptive Th2 cell functions via PD-L1 checkpoint control.

Schwartz C, Khan AR, Floudas A, Saunders SP, Hams E, Rodewald HR, McKenzie ANJ, Fallon PG.

J Exp Med. 2017 Sep 4;214(9):2507-2521. doi: 10.1084/jem.20170051. Epub 2017 Jul 26.

20.

Resolution of inflammation by interleukin-9-producing type 2 innate lymphoid cells.

Rauber S, Luber M, Weber S, Maul L, Soare A, Wohlfahrt T, Lin NY, Dietel K, Bozec A, Herrmann M, Kaplan MH, Weigmann B, Zaiss MM, Fearon U, Veale DJ, Cañete JD, Distler O, Rivellese F, Pitzalis C, Neurath MF, McKenzie ANJ, Wirtz S, Schett G, Distler JHW, Ramming A.

Nat Med. 2017 Aug;23(8):938-944. doi: 10.1038/nm.4373. Epub 2017 Jul 17.

21.

IL-17 Receptor A Maintains and Protects the Skin Barrier To Prevent Allergic Skin Inflammation.

Floudas A, Saunders SP, Moran T, Schwartz C, Hams E, Fitzgerald DC, Johnston JA, Ogg GS, McKenzie AN, Walsh PT, Fallon PG.

J Immunol. 2017 Jul 15;199(2):707-717. doi: 10.4049/jimmunol.1602185. Epub 2017 Jun 14.

22.

Type-2 innate lymphoid cells control the development of atherosclerosis in mice.

Newland SA, Mohanta S, Clément M, Taleb S, Walker JA, Nus M, Sage AP, Yin C, Hu D, Kitt LL, Finigan AJ, Rodewald HR, Binder CJ, McKenzie ANJ, Habenicht AJ, Mallat Z.

Nat Commun. 2017 Jun 7;8:15781. doi: 10.1038/ncomms15781.

23.

IFN-γ increases susceptibility to influenza A infection through suppression of group II innate lymphoid cells.

Califano D, Furuya Y, Roberts S, Avram D, McKenzie ANJ, Metzger DW.

Mucosal Immunol. 2018 Jan;11(1):209-219. doi: 10.1038/mi.2017.41. Epub 2017 May 17.

24.

Type 2 innate lymphoid cells treat and prevent acute gastrointestinal graft-versus-host disease.

Bruce DW, Stefanski HE, Vincent BG, Dant TA, Reisdorf S, Bommiasamy H, Serody DA, Wilson JE, McKinnon KP, Shlomchik WD, Armistead PM, Ting JPY, Woosley JT, Blazar BR, Zaiss DMW, McKenzie ANJ, Coghill JM, Serody JS.

J Clin Invest. 2017 May 1;127(5):1813-1825. doi: 10.1172/JCI91816. Epub 2017 Apr 4.

25.

First-Breath-Induced Type 2 Pathways Shape the Lung Immune Environment.

Saluzzo S, Gorki AD, Rana BMJ, Martins R, Scanlon S, Starkl P, Lakovits K, Hladik A, Korosec A, Sharif O, Warszawska JM, Jolin H, Mesteri I, McKenzie ANJ, Knapp S.

Cell Rep. 2017 Feb 21;18(8):1893-1905. doi: 10.1016/j.celrep.2017.01.071.

26.

STAT3 Activation Impairs the Stability of Th9 Cells.

Ulrich BJ, Verdan FF, McKenzie AN, Kaplan MH, Olson MR.

J Immunol. 2017 Mar 15;198(6):2302-2309. doi: 10.4049/jimmunol.1601624. Epub 2017 Jan 30.

27.

Single-cell RNA-seq identifies a PD-1hi ILC progenitor and defines its development pathway.

Yu Y, Tsang JC, Wang C, Clare S, Wang J, Chen X, Brandt C, Kane L, Campos LS, Lu L, Belz GT, McKenzie AN, Teichmann SA, Dougan G, Liu P.

Nature. 2016 Nov 3;539(7627):102-106. doi: 10.1038/nature20105. Epub 2016 Sep 29.

PMID:
27749818
28.

The Deubiquitinase OTULIN Is an Essential Negative Regulator of Inflammation and Autoimmunity.

Damgaard RB, Walker JA, Marco-Casanova P, Morgan NV, Titheradge HL, Elliott PR, McHale D, Maher ER, McKenzie ANJ, Komander D.

Cell. 2016 Aug 25;166(5):1215-1230.e20. doi: 10.1016/j.cell.2016.07.019. Epub 2016 Aug 11.

29.

IL-33 promotes food anaphylaxis in epicutaneously sensitized mice by targeting mast cells.

Galand C, Leyva-Castillo JM, Yoon J, Han A, Lee MS, McKenzie ANJ, Stassen M, Oyoshi MK, Finkelman FD, Geha RS.

J Allergy Clin Immunol. 2016 Nov;138(5):1356-1366. doi: 10.1016/j.jaci.2016.03.056. Epub 2016 Jun 2.

30.

Erratum to: Single cell analysis of CD4+ T cell differentiation reveals three major cell states and progressive acceleration of proliferation.

Proserpio V, Piccolo A, Haim-Vilmovsky L, Kar G, Lönnberg T, Svensson V, Pramanik J, Natarajan KN, Zhai W, Zhang X, Donati G, Kayikci M, Kotar J, McKenzie AN, Montandon R, James KR, Fernandez-Ruiz D, Heath WR, Haque A, Billker O, Woodhouse S, Cicuta P, Nicodemi M, Teichmann SA.

Genome Biol. 2016 Jun 22;17(1):133. No abstract available.

31.

Dysregulation of type 2 innate lymphoid cells and TH2 cells impairs pollutant-induced allergic airway responses.

De Grove KC, Provoost S, Hendriks RW, McKenzie ANJ, Seys LJM, Kumar S, Maes T, Brusselle GG, Joos GF.

J Allergy Clin Immunol. 2017 Jan;139(1):246-257.e4. doi: 10.1016/j.jaci.2016.03.044. Epub 2016 May 11.

32.

TIM-3 is not essential for development of airway inflammation induced by house dust mite antigens.

Hiraishi Y, Nambu A, Shibui A, Nakanishi W, Yamaguchi S, Morita H, Iikura M, McKenzie AN, Matsumoto K, Sudo K, Yamasoba T, Nagase T, Nakae S.

Allergol Int. 2016 Oct;65(4):459-465. doi: 10.1016/j.alit.2016.04.008. Epub 2016 May 18.

33.

Single-cell analysis of CD4+ T-cell differentiation reveals three major cell states and progressive acceleration of proliferation.

Proserpio V, Piccolo A, Haim-Vilmovsky L, Kar G, Lönnberg T, Svensson V, Pramanik J, Natarajan KN, Zhai W, Zhang X, Donati G, Kayikci M, Kotar J, McKenzie AN, Montandon R, Billker O, Woodhouse S, Cicuta P, Nicodemi M, Teichmann SA.

Genome Biol. 2016 May 12;17:103. doi: 10.1186/s13059-016-0957-5. Erratum in: Genome Biol. 2016;17(1):133.

34.

Respiratory syncytial virus infection activates IL-13-producing group 2 innate lymphoid cells through thymic stromal lymphopoietin.

Stier MT, Bloodworth MH, Toki S, Newcomb DC, Goleniewska K, Boyd KL, Quitalig M, Hotard AL, Moore ML, Hartert TV, Zhou B, McKenzie AN, Peebles RS Jr.

J Allergy Clin Immunol. 2016 Sep;138(3):814-824.e11. doi: 10.1016/j.jaci.2016.01.050. Epub 2016 Apr 9.

35.

IL-25/IL-33-responsive TH2 cells characterize nasal polyps with a default TH17 signature in nasal mucosa.

Lam EP, Kariyawasam HH, Rana BM, Durham SR, McKenzie AN, Powell N, Orban N, Lennartz-Walker M, Hopkins C, Ying S, Rimmer J, Lund VJ, Cousins DJ, Till SJ.

J Allergy Clin Immunol. 2016 May;137(5):1514-24. doi: 10.1016/j.jaci.2015.10.019. Epub 2015 Dec 10.

36.

Group 2 Innate Lymphoid Cells Express Functional NKp30 Receptor Inducing Type 2 Cytokine Production.

Salimi M, Xue L, Jolin H, Hardman C, Cousins DJ, McKenzie AN, Ogg GS.

J Immunol. 2016 Jan 1;196(1):45-54. doi: 10.4049/jimmunol.1501102. Epub 2015 Nov 18.

37.

Group 2 innate lymphoid cells license dendritic cells to potentiate memory TH2 cell responses.

Halim TY, Hwang YY, Scanlon ST, Zaghouani H, Garbi N, Fallon PG, McKenzie AN.

Nat Immunol. 2016 Jan;17(1):57-64. doi: 10.1038/ni.3294. Epub 2015 Nov 2.

38.

The helminth T2 RNase ω1 promotes metabolic homeostasis in an IL-33- and group 2 innate lymphoid cell-dependent mechanism.

Hams E, Bermingham R, Wurlod FA, Hogan AE, O'Shea D, Preston RJ, Rodewald HR, McKenzie AN, Fallon PG.

FASEB J. 2016 Feb;30(2):824-35. doi: 10.1096/fj.15-277822. Epub 2015 Oct 21.

39.

Spontaneous atopic dermatitis is mediated by innate immunity, with the secondary lung inflammation of the atopic march requiring adaptive immunity.

Saunders SP, Moran T, Floudas A, Wurlod F, Kaszlikowska A, Salimi M, Quinn EM, Oliphant CJ, Núñez G, McManus R, Hams E, Irvine AD, McKenzie AN, Ogg GS, Fallon PG.

J Allergy Clin Immunol. 2016 Feb;137(2):482-91. doi: 10.1016/j.jaci.2015.06.045. Epub 2015 Aug 20.

40.

An Interleukin-33-Mast Cell-Interleukin-2 Axis Suppresses Papain-Induced Allergic Inflammation by Promoting Regulatory T Cell Numbers.

Morita H, Arae K, Unno H, Miyauchi K, Toyama S, Nambu A, Oboki K, Ohno T, Motomura K, Matsuda A, Yamaguchi S, Narushima S, Kajiwara N, Iikura M, Suto H, McKenzie AN, Takahashi T, Karasuyama H, Okumura K, Azuma M, Moro K, Akdis CA, Galli SJ, Koyasu S, Kubo M, Sudo K, Saito H, Matsumoto K, Nakae S.

Immunity. 2015 Jul 21;43(1):175-86. doi: 10.1016/j.immuni.2015.06.021.

41.

Inflammation-induced formation of fat-associated lymphoid clusters.

Bénézech C, Luu NT, Walker JA, Kruglov AA, Loo Y, Nakamura K, Zhang Y, Nayar S, Jones LH, Flores-Langarica A, McIntosh A, Marshall J, Barone F, Besra G, Miles K, Allen JE, Gray M, Kollias G, Cunningham AF, Withers DR, Toellner KM, Jones ND, Veldhoen M, Nedospasov SA, McKenzie ANJ, Caamaño JH.

Nat Immunol. 2015 Aug;16(8):819-828. doi: 10.1038/ni.3215. Epub 2015 Jun 29.

42.

IL-25 as a potential therapeutic target in allergic asthma.

Knolle MD, Rana BM, McKenzie AN.

Immunotherapy. 2015;7(6):607-10. doi: 10.2217/imt.15.36. Epub 2015 Jun 23. No abstract available.

PMID:
26100272
43.

Innate lymphoid cells. Innate lymphoid cells: a new paradigm in immunology.

Eberl G, Colonna M, Di Santo JP, McKenzie AN.

Science. 2015 May 22;348(6237):aaa6566. doi: 10.1126/science.aaa6566. Epub 2015 May 21. Review.

44.

Bcl11b is essential for group 2 innate lymphoid cell development.

Walker JA, Oliphant CJ, Englezakis A, Yu Y, Clare S, Rodewald HR, Belz G, Liu P, Fallon PG, McKenzie AN.

J Exp Med. 2015 Jun 1;212(6):875-82. doi: 10.1084/jem.20142224. Epub 2015 May 11.

45.

A dominant role for the methyl-CpG-binding protein Mbd2 in controlling Th2 induction by dendritic cells.

Cook PC, Owen H, Deaton AM, Borger JG, Brown SL, Clouaire T, Jones GR, Jones LH, Lundie RJ, Marley AK, Morrison VL, Phythian-Adams AT, Wachter E, Webb LM, Sutherland TE, Thomas GD, Grainger JR, Selfridge J, McKenzie AN, Allen JE, Fagerholm SC, Maizels RM, Ivens AC, Bird A, MacDonald AS.

Nat Commun. 2015 Apr 24;6:6920. doi: 10.1038/ncomms7920.

46.

IL-9 regulates intestinal barrier function in experimental T cell-mediated colitis.

Gerlach K, McKenzie AN, Neurath MF, Weigmann B.

Tissue Barriers. 2015 Apr 3;3(1-2):e983777. doi: 10.4161/21688370.2014.983777. eCollection 2015.

47.

Deciphering the transcriptional switches of innate lymphoid cell programming: the right factors at the right time.

Lim AW, McKenzie AN.

Genes Immun. 2015 Apr-May;16(3):177-86. doi: 10.1038/gene.2014.83. Epub 2015 Jan 22. Review.

48.

Type-2 innate lymphoid cells in asthma and allergy.

McKenzie AN.

Ann Am Thorac Soc. 2014 Dec;11 Suppl 5:S263-70. doi: 10.1513/AnnalsATS.201403-097AW. Review.

49.

The messenger between worlds: the regulation of innate and adaptive type-2 immunity by innate lymphoid cells.

Scanlon ST, McKenzie AN.

Clin Exp Allergy. 2015 Jan;45(1):9-20. doi: 10.1111/cea.12464. Review.

PMID:
25423949
50.

Innate lymphoid cells in inflammation and immunity.

McKenzie ANJ, Spits H, Eberl G.

Immunity. 2014 Sep 18;41(3):366-374. doi: 10.1016/j.immuni.2014.09.006. Review.

Supplemental Content

Loading ...
Support Center